Shopping Cart
- Remove All
- Your shopping cart is currently empty
LY117018 shows antiproliferative effects on breast cancer cell lines. LY117018 is a Raloxifene analog and is a selective estrogen receptor modulator.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | LY117018 shows antiproliferative effects on breast cancer cell lines. LY117018 is a Raloxifene analog and is a selective estrogen receptor modulator. |
In vitro | LY117018 (1 μM) treatment, caused a predominantly hypophosphorylated pRb. At a higher concentration of LY117018 (1 μM), the level of p53 appeared to decline. LY117018 (0.01-1000 nM; 24 hours) at lower concentrations (0.01-10 nM) caused an E2-like increase in p53 levels when compared to its effects on cells grown in the stripped medium. LY117018 did not block E2-induced pRb phosphorylation, at lower concentrations[1]. LY117018 (1 μM; 96 hours) suppresses MCF-7 cell proliferation with an IC50 of 1 μM[2]. LY117018 inhibits oxidative stress-induced endothelial cell apoptosis through activation of ERK1/2 signaling pathway[3]. |
Molecular Weight | 459.56 |
Formula | C27H25NO4S |
Cas No. | 63676-25-5 |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.